Multidrug-resistant tuberculosis and its control.
Kochi
A
A
World Health Organization Tuberculosis Programme, Geneva, Switzerland.
Vareldzis
B
B
Styblo
K
K
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin